A Current Overview of Spreading Mechanism and Treatment of Monkeypox Virus

Untitled DocumentOutside of Africa, the monkeypox epidemic has returned in 2022. The MPXV spreads from body to body via inhaling droplets, inadvertent contact with contaminated objects, or direct connection with infectious skin. Different epidemiological and clinical characteristics distinguish the illness brought on by the MPXV clades. Comparable to smallpox, the MPXV infection has a lower fatality rate (10%) and a milder form. This virus has developed new features that allow it to spread rapidly. There are currently no specific vaccines or medications that can prevent MPXV infection, despite the fact that smallpox immunization has been found to offer 85% protection against MPXV infection and the promise of 2 anti-smallpox virus treatments for MPXV. The decision to end the national smallpox immunization programs in many nations should thus be given further thought. However, it is highly challenging to establish the disease and identify its cause based solely on clinical symptoms in the absence of reliable diagnostic testing. Strategies for MPXV prevention and treatment, as well as laboratory diagnosis. This study offers the fundamental information needed to stop and manage any further spread of this virus.